163 related articles for article (PubMed ID: 27591090)
1. Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma.
Ma HL; Jin SF; Tao WJ; Zhang ML; Zhang ZY
J Craniomaxillofac Surg; 2016 Oct; 44(10):1725-1732. PubMed ID: 27591090
[TBL] [Abstract][Full Text] [Related]
2. Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma.
Ma HL; Jin SF; Ju WT; Fu Y; Tu YY; Wang LZ; Jiang-Li ; Zhang ZY; Zhong LP
J Exp Clin Cancer Res; 2017 Aug; 36(1):109. PubMed ID: 28806997
[TBL] [Abstract][Full Text] [Related]
3. High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
Harada K; Ferdous T; Harada T; Ueyama Y
Clin Exp Med; 2017 Feb; 17(1):45-50. PubMed ID: 26590596
[TBL] [Abstract][Full Text] [Related]
4. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
[TBL] [Abstract][Full Text] [Related]
5. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
[TBL] [Abstract][Full Text] [Related]
6. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
[TBL] [Abstract][Full Text] [Related]
7. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
8. The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma.
Yang L; Wang Y; Guo L; Wang L; Chen W; Shi B
Biomed Res Int; 2015; 2015():637853. PubMed ID: 26523280
[TBL] [Abstract][Full Text] [Related]
9. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
10. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis.
Kouzu Y; Uzawa K; Koike H; Saito K; Nakashima D; Higo M; Endo Y; Kasamatsu A; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Br J Cancer; 2006 Mar; 94(5):717-23. PubMed ID: 16495930
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 gene in oral squamous cell carcinoma and its relation with clinical and pathological parameters and prognosis of patients.
Mao C; Lu Y; Lai Q; Xia Y; Yang C
Chin Med Sci J; 1995 Dec; 10(4):199-203. PubMed ID: 8745578
[TBL] [Abstract][Full Text] [Related]
15. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
[TBL] [Abstract][Full Text] [Related]
16. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH
Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
19. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
Xi W; Rui W; Fang L; Ke D; Ping G; Hui-Zhong Z
J Cancer Res Clin Oncol; 2009 Jun; 135(6):837-46. PubMed ID: 19034510
[TBL] [Abstract][Full Text] [Related]
20. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]